Skip to main content
. 2012 Sep 20;15(9):507–512. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2012.09.02

2.

GN方案在晚期NSCLC的二线及二线以上治疗的短期疗效比较

Short-term efficacy of GN regimen as second-line or further-line therapy for patients with advanced NSCLC

Best response Second-line (n=28) Third-line (n=25)
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; ORR: objective response rate; DCR: disease control rate; NSCLC: non-small cell lung cancer.
CR 0 0
PR 3 2
SD 13 11
PD 12 12
ORR 10.7% 7.1%
DCR 57.1% 52.0%